Cell line name |
Bx-GEM200 |
Synonyms |
BxPc-3-GEM |
Accession |
CVCL_E4NH |
Resource Identification Initiative |
To cite this cell line use: Bx-GEM200 (RRID:CVCL_E4NH) |
Comments |
Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar). Derived from site: In situ; Pancreas; UBERON=UBERON_0001264. |
Sequence variations |
- Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
- Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
|
Disease |
Pancreatic ductal adenocarcinoma (NCIt: C9120) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Hierarchy |
Parent: CVCL_E4NG (Bx-GEM100) |
Sex of cell |
Female |
Age at sampling |
61Y |
Category |
Cancer cell line |
Publications | PubMed=26828016; DOI=10.1016/j.canlet.2016.01.038 Pei Fan, Li Liu, Ye-Feng Yin, Zhe-Fu Zhao, Yi-Yao Zhang, Prince Saforo Amponsah, Xi Xiao, Nathalie Bauer, Alia Abukiwan, Clifford C. Nwaeburu, Jury Gladkich ...Show all 15 authors... , Chao Gao, Peter Schemmer, Wolfgang Gross, Ingrid Herr; Show fewer authors MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Cancer Lett. 373:130-137(2016) |
Entry history |
Entry creation | 19-Dec-2024 |
Last entry update | 19-Dec-2024 |
Version number | 1 |
---|